<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02026765</url>
  </required_header>
  <id_info>
    <org_study_id>5AT-6M</org_study_id>
    <nct_id>NCT02026765</nct_id>
  </id_info>
  <brief_title>Clinical Outcomes About Heparin Surface Modified Aspheric Lens</brief_title>
  <official_title>Clinical Outcomes About Heparin Surface Modified Aspheric Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wenzhou Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wenzhou Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obverse the effect of this type lens in the same as
      traditional aspheric intraocular lens at the same time, whether can further improve the
      effects of operation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Heparin surface treatment lens can reduce inflammatory reaction.

        2. Modified aspheric lens are more in line with human optical properties than the
           traditional aspheric lens.

        3. To obverse the effect of this type lens in the same as traditional aspheric intraocular
           lens at the same time, whether can further improve the effects of operation.

        4. After one day, one week, one month, three month follow-up，Key observation on the flare,
           the optical quality, contrast sensitivity and other parameters.Study the postoperative
           inflammatory reaction with test group lens，and the impact on the visual quality.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>flare value in the anterior chamber after surgery</measure>
    <time_frame>six months</time_frame>
    <description>use Laser Flare Meter to measure the flare in the anterior chamber to evaluate postoperative ocular inflammatory reaction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the ocular and the anterior corneal aberration after surgery</measure>
    <time_frame>six months</time_frame>
    <description>use wavefront aberrometer to measure the ocular and the anterior corneal aberration to evaluate postoperative ocular optical quality</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Inflammatory Reaction</condition>
  <arm_group>
    <arm_group_label>Heparin Surface Modified Aspheric Lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Heparin Surface Modified Aspheric Lens</description>
  </arm_group>
  <arm_group>
    <arm_group_label>traditional lens</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>traditional Aspheric lens</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>traditional lens</intervention_name>
    <description>A random eyes with traditional lens</description>
    <arm_group_label>traditional lens</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>heparin surface modified aspheric lens</intervention_name>
    <description>the other eye implant heparin surface modified aspheric lens</description>
    <arm_group_label>Heparin Surface Modified Aspheric Lens</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cataract patients

        Exclusion Criteria:

          -  Eyed patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AYong Yu, MD. PhD.</last_name>
    <role>Study Director</role>
    <affiliation>Wenzhou Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Affiliated Eye hospital of Wenzhou Medical University</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325000</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2013</study_first_submitted>
  <study_first_submitted_qc>January 1, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 3, 2014</study_first_posted>
  <last_update_submitted>December 8, 2015</last_update_submitted>
  <last_update_submitted_qc>December 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wenzhou Medical University</investigator_affiliation>
    <investigator_full_name>A-Yong Yu</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium heparin</mesh_term>
    <mesh_term>Heparin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

